Continuous glucose monitors (CGMs), insulin pumps and insulin pump consumables: Procurement status
Find the latest information on Pharmac’s procurement process for continuous glucose monitoring (CGM) devices, insulin pumps and insulin pump consumables.
Update 28 March 2024
We have reached provisional agreements with suppliers and now we need your feedback.
Contracted with preferred suppliers
Pharmac has concluded its evaluation and contracted with the preferred suppliers.
We received bids from a number of suppliers in response to the Request for Proposals (RFP) for the supply of CGMs, insulin pumps and insulin pump consumables.
To assess these bids, we held three evaluation committee meetings, including clinical experts, consumer representatives, and Pharmac staff.
Pharmac uses information gathered during the evaluation meetings, alongside the Factors for Consideration, to select the preferred suppliers.
About Requests for Proposals (RFPs)
Timing of the procurement process
Pharmac initially signalled interest in funding CGMs and considering the supply of insulin pumps and insulin pump consumables in February 2023.
We understand people would like to know how long this procurement process will take. Below we have noted the milestones we have worked to so far.
Unfortunately, the time required to undertake contractual negotiations with suppliers can vary. As such, we can’t be certain about future timings for this process. However, we will share updates on this webpage as more information becomes available.
Milestone | Date |
---|---|
FPO release | Complete (Feb 2023) |
Clinical advice | Complete (April 2023) |
Publishing records of clinical advice from the diabetes Specialist Advisory Committee | Complete (July 2023) |
RFP release | Complete (July 2023) |
Supplier briefing | Complete (July 2023) |
Stakeholder briefing | Complete (August 2023) |
Bids close | Complete (August 2023) |
Evaluation committee meetings and seeking further clinical advice | Complete (October-November 2023) |
Contracting with preferred suppliers | Complete (March 2024) |
Consultation period | 28 March to 26 April 2024 |
Pharmac Board meeting | mid 2024 |
Decision notification date | To be decided: 2024 |
Provisional implementation date | To be confirmed: 1 July 2024 and 1 October 2024 |
The funding application
Pharmac has previously received funding applications for Dexcom, FreeStyle Libre and Medtronic CGMs.
For many of the 17,000 New Zealanders living with type 1 diabetes having funded access to these devices would be life changing.
Applications Pharmac received prior to this process
Who to contact
We will update this page as more information becomes available.
Sign up for email notifications(external link)
If your question is not answered here, email enquiry@pharmac.govt.nz